Loss of the wild-type allele contributes to myeloid expansion and disease aggressiveness in FLT3/ITD knockin mice
- 3 November 2011
- journal article
- Published by American Society of Hematology in Blood
- Vol. 118 (18), 4935-4945
- https://doi.org/10.1182/blood-2011-01-328096
Abstract
Clinical evidence has shown that FLT3 internal tandem duplication (ITD) mutation confers poor prognosis in acute myeloid leukemia. Loss of the FLT3 wild-type (WT) allele is associated with even worse prognosis. We have previously reported that heterozygous FLT3wt/ITD “knockin” mice develop a slowly fatal myeloproliferative neoplasm (MPN). To study the roles of the WT FLT3 and ITD alleles in the development of MPNs, we generated FLT3/ITD homozygous (FLT3ITD/ITD) and hemizygous (FLT3−/ITD) mice. FLT3−/ITD mice, with the loss of WT allele, display a more severe MPN, as evidenced by even larger spleen, higher white blood cell counts, and shorter survival, compared with FLT3wt/ITD mice. Reintroduction of the WT FLT3 allele into FLT3−/ITD BM slowed the progression of MPN in recipient mice. FLT3ITD/ITD mice had an even severe MPN compared with the FLT3−/ITD and FLT3wt/ITD mice. Spontaneous leukemia developed in a small fraction of the FLT3ITD/ITD mice but was never observed in the FLT3−/ITD and FLT3wt/ITD mice. Our results suggest that loss of the WT allele contributes to the development of a more severe phenotype. Thus, the WT FLT3 allele seemingly functions as a tumor suppressor, attenuating the function of the FLT3/ITD allele in leukemia harboring FLT3/ITD mutations.Keywords
This publication has 44 references indexed in Scilit:
- Defective nonhomologous end joining blocks B-cell development in FLT3/ITD miceBlood, 2011
- Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignanciesBlood, 2010
- Genomic analysis of acute myeloid leukemia: potential for new prognostic indicatorsCurrent Opinion in Hematology, 2010
- Whole genome scanning as a cytogenetic tool in hematologic malignanciesBlood, 2008
- Knock-in of an internal tandem duplication mutation into murine FLT3 confers myeloproliferative disease in a mouse modelBlood, 2008
- Abnormal Localization and Accumulation of FLT3-ITD, a Mutant Receptor Tyrosine Kinase Involved in LeukemogenesisCells Tissues Organs, 2008
- FLT3 Mutations Confer Enhanced Proliferation and Survival Properties to Multipotent Progenitors in a Murine Model of Chronic Myelomonocytic LeukemiaCancer Cell, 2007
- Identification of Flt3+ Lympho-Myeloid Stem Cells Lacking Erythro-Megakaryocytic PotentialCell, 2005
- Array CGH technologies and their applications to cancer genomesChromosome Research, 2005
- FLT3: ITDoes matter in leukemiaLeukemia, 2003